Stifel Financial Corp Coherus Bio Sciences, Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$2.02 - $3.14 $9,041 - $14,054	-4,476 Reduced 8.23%	49,925 $119,000
Q4 2023 Feb 12, 2024	SELL	$1.59 - $3.85 $24,991 - $60,514	-15,718 Reduced 22.42%	54,401 $181,000
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $262,245 - $382,148	70,119 New	70,119 $262,000
Q3 2018 Nov 13, 2018	SELL	$14.45 - $20.25 $560,746 - $785,821	-38,806 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$10.25 - $17.45 $397,761 - $677,164	38,806 New	38,806 $544,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.